Moreover, another study showed that TRPM8 agonists such as menthol could increase Kir4.1-mediated cell membrane conductivity in U251 GBM cells.180 Therefore, all the above evidence proves that the TRPM8 channels are a promising candidate for targeted glioma therapy. This evidence concerns the gene KCNJ10 and glioma.